Dr. Reddy's Laboratories Limited (RDY)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 11.87B |
| Enterprise value | 11.24B |
| Trailing P/E | 18.94 |
| Forward P/E | 19.42 |
| PEG ratio (5-yr expected) | 4.69 |
| Price/sales (ttm) | 3.64 |
| Price/book (mrq) | 3.69 |
| Enterprise value/revenue | 0.04 |
| Enterprise value/EBITDA | 0.13 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.34 |
| 52-week change 3 | 17.32% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 77.72 |
| 52-week low 3 | 53.12 |
| 50-day moving average 3 | 74.44 |
| 200-day moving average 3 | 69.40 |
Share statistics
| Avg vol (3-month) 3 | 195.37k |
| Avg vol (10-day) 3 | 170.59k |
| Shares outstanding 5 | 166.52M |
| Implied shares outstanding 6 | 167.4M |
| Float 8 | 119.82M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 15.03% |
| Shares short (28 Mar 2024) 4 | 625.76k |
| Short ratio (28 Mar 2024) 4 | 3.51 |
| Short % of float (28 Mar 2024) 4 | N/A |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.38% |
| Shares short (prior month 29 Feb 2024) 4 | 648.12k |
Dividends & splits
| Forward annual dividend rate 4 | 0.49 |
| Forward annual dividend yield 4 | 0.69% |
| Trailing annual dividend rate 3 | 40.00 |
| Trailing annual dividend yield 3 | 56.09% |
| 5-year average dividend yield 4 | 0.72 |
| Payout ratio 4 | 12.78% |
| Dividend date 3 | 11 Aug 2023 |
| Ex-dividend date 4 | 07 Jul 2023 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 07 Sept 2006 |
Financial highlights
Currency in INR.Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 19.24% |
| Operating margin (ttm) | 24.74% |
Management effectiveness
| Return on assets (ttm) | 12.38% |
| Return on equity (ttm) | 21.39% |
Income statement
| Revenue (ttm) | 271.3B |
| Revenue per share (ttm) | 272.46 |
| Quarterly revenue growth (yoy) | 6.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 80.98B |
| Net income avi to common (ttm) | 52.21B |
| Diluted EPS (ttm) | 3.74 |
| Quarterly earnings growth (yoy) | 10.60% |
Balance sheet
| Total cash (mrq) | 72.55B |
| Total cash per share (mrq) | 435.7 |
| Total debt (mrq) | 19.85B |
| Total debt/equity (mrq) | 7.41% |
| Current ratio (mrq) | 2.55 |
| Book value per share (mrq) | 1,608.58 |
Cash flow statement
| Operating cash flow (ttm) | 53.59B |
| Levered free cash flow (ttm) | 23.21B |
© 2024 Yahoo. All rights reserved.